期刊文献+

玫瑰孢链霉菌NRRL11379产达托霉素前体物A21978C的发酵培养基优化 被引量:7

Optimization Study on Fermentative Medium for Precursor of Daptomycin A21978C Produced by Streptomyces roseosporus NRRL 11379
下载PDF
导出
摘要 [目的]对玫瑰孢链霉菌NRRL 11379进行发酵培养基优化,寻找产物A21978C较好的发酵培养基配方。[方法]从16种发酵培养基中筛选较好的培养基,通过单因子试验和正交试验进行优化。[结果]得到玫瑰孢链霉菌NRRL 11379产达托霉素前体物A21978C组分的最佳发酵培养基为:葡萄糖1%、可溶性淀粉4%、黄豆粉1%(、NH4)2SO40.3%、MOPS 6%、K2SO40.8%、NaCl 0.1%。[结论]优化后的产量约为60 mg/L,比优化前提高9.2倍。 [Objective] The fermentative medium on Streptomyces roseosporus NRRL11379 was optimized,and a better fermentative medium formula of product A21978C was searched.[Method] The better culture medium was screened from 16 kinds of the fermentative medium,and optimized by single factor and orthogonal experiments.[Result] The optimum fermentative medium obtained from daptomycin precursor A21978C produced by S.roseosporus was 1% glucose,4% soluble starch,1% soybean flour,0.3%(NH4)2SO4,6% MOPS,0.8% K2SO4,0.1% NaCl.[Conclusion] The yield after optimization was 60 mg/L,which was 9.2 times higher than that before optimization.
出处 《安徽农业科学》 CAS 北大核心 2008年第19期7974-7976,共3页 Journal of Anhui Agricultural Sciences
基金 科技部社会公益项目(2004DIB3J072)
关键词 达托霉素 玫瑰孢链霉菌 发酵培养基 MRSA Daptomycin Streptomyces roseosporus Fermentative medium MRSA
  • 相关文献

参考文献5

二级参考文献25

共引文献41

同被引文献59

  • 1张乐乐,许激扬,陈代杰.链阳菌素的作用机制与细菌耐药性[J].世界临床药物,2009,30(11):684-689. 被引量:8
  • 2李格,贾海忠.史载祥教授治疗MRSA感染致发热验案1例[J].北京中医药大学学报(中医临床版),2006,13(3):28-29. 被引量:3
  • 3卢文玉,闻建平,范晶华,曹博翔,孙冰.激光诱变玫瑰孢链霉菌结合链霉素抗性筛选法选育达托霉素高产菌株[J].微生物学通报,2006,33(3):114-117. 被引量:28
  • 4卢文玉,闻建平,范晶华,孙冰,曹博翔,闻建华.癸酸抗性突变株流加发酵法生产达托霉素[J].天津大学学报,2006,39(B06):20-24. 被引量:17
  • 5Michael A P, Helio S S, Ronald N J. Evaluation of the invitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North Americanhospitals (2000-2005) [J]. Diagn Microbiol Infec Dis, 2007, 57(4): 459-465.
  • 6Miao V, Coeffet-LeGal M F, Brian P, et al. Daptomycin biosynthesis in Streptomyces roseosporus: cloning and analysis of the gene cluster and revision of peptide stereochemistry[J]. Microbiology, 2005, 151: 1507-1523.
  • 7Baltz R H,Miao V,Wrigley S K,et al.Natural products to drugs:Daptomycin and related lipopeptide antibiotics[J].Natural ProductReports,2005,22(6):717-741.
  • 8Steenbergen J N,Alder J,Thorne G M,et al.Daptomycin:Alipopeptide antibiotic for the treatment of serious Gram-positiveinfections[J].Journal of Antimicrobiology and Chemotherapy,2005,55(3):283-288.
  • 9Arbeit R D,Maki D,Tally F P,et al.The safety and efficacy ofdaptomycin for the treatment of complicated skin and skin-structureinfections[J].Clinical Infectious Diseases,2004,38(12):1673-1681.
  • 10Fowler V G,Boucher H W,Corey G R,et al.Daptomycin versusstandard therapy for bacteremia and endocarditis caused byStaphylococcus aureus[J].New England Journal of Medicine,2006,355(7):653-655.

引证文献7

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部